Request Deal Involvement
Brooklyn ImmunoTherapeutics completed the acquisition of Novellus Therapeutics for $125m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Core IR
financial advisors
Back Bay Life Science Advisors
legal advisors to financial advisors
White & Case
or
Principals
bidder
BROOKLYN IMMUNOTHERAPEUTICS
target
NOVELLUS THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite